RMP
OM icon

Richards, Merrill & Peterson’s Outset Medical OM Stock Holding History

Richards, Merrill & Peterson’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$2.21K – 389
2025
Q1 		$2.21K Hold
200
– – ﹤0.01% 470
2024
Q4 		$3.33K Buy
+200
New +$2.5K ﹤0.01% 445

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Richards, Merrill & Peterson's OM Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Outset Medical (OM) in Q2 2025, closing a stake of 200 shares — an estimated $2.21K sold.

Richards, Merrill & Peterson first reported a position in OM in Q4 2024 and held it in 2 quarters. The position peaked at $3.33K in Q4 2024. 94 funds tracked by Wall St. Rank hold OM as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining Outset Medical position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 200 Outset Medical shares in Q2 2025, an estimated $2.21K.
  • Richards, Merrill & Peterson first reported a position in Outset Medical in Q4 2024 and held it in 2 quarters.
  • Richards, Merrill & Peterson's Outset Medical position peaked at $3.33K in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Outset Medical as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.